Pristinamycin
Pristinamycin is a streptogramin-class antibiotic used to treat certain bacterial infections, particularly infections caused by susceptible Gram-positive bacteria, including some strains resistant to other antibiotics. It works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing bacterial growth. It is primarily available as oral tablets in countries where it is approved and marketed. Common side effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Allergic reactions and liver-related adverse effects may occur less commonly. Pristinamycin should be prescribed according to bacterial susceptibility and local treatment guidelines, with appropriate medical supervision to ensure effective and responsible antibiotic use.
Pristinamycin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Pristinamycin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Pristinamycin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Pristinamycin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
